Use of Khadiradi lepa in fungal infections of skin

A Single arm clinical study to evaluate the efficacy of Khadiradi lepa in the management of Dadru - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/04/066426

Enrollment

Registered

2024-04-29

Start date

Unknown

Completion date

Unknown

Last updated

2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients with classical clinical features of Dadru (kandu, raga, pidaka, daha, rookshata, udgata mandala) irrespective of chronicity.

Exclusion criteria

Exclusion criteria: Chronic illness and infection like TB, DM, Skin cancer, Psoriasis, Hansen’s disease, generalized eczema, malignant conditions. Person who is taking modern medicine for Dadru. Patients associated with other type of Kushtha. Lesions with secondary infections.

Design outcomes

Primary

Measure	Time frame
To reduce the intensity of the symptoms of Dadru which are Kandu (itch), Daha (burning sensation), Utsanna Mandala (elevated borders), Raaga (erythema) and Pidaka (discoid lesions)Timepoint: 14 days study with 2 follow up (0,7,14 days)	—

Secondary

Measure	Time frame
To observe adverse effect if any.Timepoint: 14 days study with 2 follow up (0,7,14 days)	—

Countries

India

Contacts

Public ContactDr Bhavana A

Dr D Y Patil college of Ayurved and research centre

gunvantayurved@gmail.com9028321955

Outcome results